Viewing Study NCT07079267


Ignite Creation Date: 2025-12-25 @ 12:34 AM
Ignite Modification Date: 2026-02-22 @ 3:19 AM
Study NCT ID: NCT07079267
Status: AVAILABLE
Last Update Posted: 2025-07-23
First Post: 2025-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olpasiran Expanded Access Program
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module